about
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary InterventionsNon-coding RNAs: the "dark matter" of cardiovascular pathophysiology.MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.A novel quick and easy test for radial artery occlusion with the laser Doppler scan.Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-AnalysisImpact of intracoronary adenosine administration during primary PCI: A meta-analysis.The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTsRenal sympathetic denervation for treating resistant hypertension.Clinical Usefulness of a Mobile Application for the Appropriate Selection of the Antiarrhythmic Device in Heart Failure.Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report.Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor.Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis.Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds.Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery.Diagnostic Performance of the Instantaneous Wave-Free Ratio: Comparison With Fractional Flow Reserve.Transcoronary concentration gradients of circulating microRNAs in heart failure.Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds Three years follow-up in a cohort of consecutive patients.The instantaneous wave-free ratio (iFR) for evaluation of non-culprit lesions in patients with acute coronary syndrome and multivessel disease.First case of subcutaneous implantable cardioverter-defibrillator extrusion.Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot StudyNon-coding RNAs in vascular remodeling and restenosisProcedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the "PSP" TechniqueBioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysisBioresorbable vascular scaffold: a step back thinking of the future.Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivoBioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled TrialsPredictors of stent thrombosis and their implications for clinical practicePredictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-upRadial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel ApproachesAntithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart InterventionsFive Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular ScaffoldsReliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery LesionsReply to 'Relationship between stent fracture and thrombosis'Myocardial infarction after dog bite
P50
Q26771570-5CBCD130-3BE4-47CD-AD52-9C80041A4FD4Q27693295-F94292BB-AB90-49BF-9409-EB1BE8869F8BQ34906347-0A42C392-728F-4EB9-8362-01BB65F81DC5Q35217848-E1776193-0E06-492A-8EAC-2DF14E56486CQ35631782-A0F19441-675D-4898-9E41-F1BBACEA1C81Q35859196-E0A12A70-55EF-48E0-98D0-614AD2419C40Q35865733-9CD0ECEA-69E5-4D0C-AD7E-14EA7FF415E7Q36395245-DAD44A14-D451-49BB-986B-840A877DAC8CQ38091560-10453CDD-7A1E-4449-9A15-A3B9072312CFQ40366318-39F47FF8-45DE-444D-BAC4-643ED6E80A86Q41437547-06732A4C-4832-4EA9-85B1-B86286CB2E34Q41591376-4E5E2ECC-DDB0-4819-A634-8A3307DEFEEEQ42246588-B4D02AD3-BEC9-4E18-8838-8B62F5637C88Q47178436-FF3E88AB-6B6E-4FC5-9D6D-4EF77802A4D8Q47946688-2C0B48E8-FA29-44DC-A74B-5BDC2E7A27D7Q48239504-05E76BEC-659E-4927-BBF0-086AD9EA0871Q50078244-90B6ED84-1044-482A-9892-1CD20C3A7D16Q50123005-1FD9AAF3-484D-4597-B7B8-0A817481F9D8Q50266416-CC958609-9C7C-4A17-877B-8472E837DDC9Q51000962-46CE3461-4CBB-4D0F-AEE1-F37E74169BD8Q53233302-8EBBC5B8-F696-46FD-8AB9-CAA0AA3C430EQ55015201-559FE3DC-6CC1-440C-8BD1-A4CA2AD48DA9Q57047064-D7428E49-A735-42C3-A6DC-8D3DF98C2821Q58119083-39C1CAA8-328C-4C64-9153-CAF5A79F3D89Q61816894-6FDB40C6-9D26-4FAE-9618-48FF9495C3E9Q64085672-05C7CA86-FF7E-439F-8167-19B5B86C91A6Q64879831-00D8261E-06CB-44E1-9F2F-2FC86329F591Q87347536-652A9541-51CB-4A5D-9895-9859EF103D12Q88306860-764172A7-15DC-4E0C-9927-EE12D832E4AFQ90074542-29B87454-578D-4E4B-890E-A0B514606B6CQ90288915-49ACC821-8F3E-40F9-A3C6-A18BA9A48AFCQ90448961-21743FD8-E9A1-40CF-85B4-8E85309810E3Q90852450-740EC10D-D520-4D03-A1DF-0CCA95DCD18DQ91377741-F73F1869-7549-4E2D-A058-B544561A8C98Q91546920-80BB09E2-B9B9-4E4E-B6BC-08FEECF16236Q92344725-4A716F65-1AA5-44C3-98FB-49F3E228B14BQ92995832-2D377ADB-BE5B-47AF-9390-9020EEC4C859Q93367114-16AE9790-0572-40AE-997A-7600D806BE5B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alberto Polimeni
@ast
Alberto Polimeni
@en
Alberto Polimeni
@es
Alberto Polimeni
@nl
type
label
Alberto Polimeni
@ast
Alberto Polimeni
@en
Alberto Polimeni
@es
Alberto Polimeni
@nl
prefLabel
Alberto Polimeni
@ast
Alberto Polimeni
@en
Alberto Polimeni
@es
Alberto Polimeni
@nl
P106
P1153
55331621200
P21
P31
P496
0000-0002-9166-3031